ACC 2021
American College of Cardiology 70th Annual Scientific Session & Expo 2021
May 15-17, 2021 | Virtual
CSL Behring was proud to support the Virtual Industry-Expert Theater at the American College of Cardiology 70th Annual Scientific Session & Expo 2021, titled “Re-imagining the 90-Day High-Risk Period Post-AMI: Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization”. During this live panel discussion, distinguished experts Prof. C. Michael Gibson, Prof. Roxana Mehran, and Prof. Philippe G. Steg discussed the risk and incidence of recurrent CV events post-AMI, and the role of cholesterol efflux and ApoA-I in plaque stabilization.
Symposium Video
Re-imagining the 90-Day High-Risk Period Post-AMI: Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization
Chaired by: Prof. C. Michael Gibson
Co-presented by: Prof. Roxana Mehran and Prof. Philippe G. Steg
Duration: 53:40
Educational Resources
Re-imagining the 90-Day High-Risk Period Post-AMI Congress Highlights
Prof. C. Michael Gibson, Prof. Roxana Mehran, and Prof. Philippe G. Steg
Cholesterol Efflux and Cardiovascular Outcomes
Listen to Prof. C. Michael Gibson as he explores the association between CEC and adverse CV events. He also discusses the potential of CEC as a novel therapeutic target to improve outcomes for patients with CV disease.
1. Lee et al., 2021
Risk and Incidence of Recurrent CV Events Post-ACS: A Meta-Analysis
Listen to Prof. C. Michael Gibson discuss the risks associated with early and late recurrent events in patients with recent ACS, and the implications this could have on trial design.
1. Chi et al., 2021
Legend
- ACS, acute coronary syndrome;AMI, acute myocardial infarction; ApoA-I, apolipoprotein A1; CEC, cholesterol efflux capacity; CV, cardiovascular.
CMD-CRP-0004
January 2023